WASHINGTON (AP) - The Food and Drug Administration on Tuesday approved a new heart pump for patients with severe heart failure who are awaiting a heart transplant.
Regulators approved HeartWare's Ventricular Assist System, a battery-powered device that is implanted in the chest, where it helps the heart's lower left chamber pump blood throughout the body.
The FDA has previously approved similar devices, known as ventricular assist devices, but HeartWare's device is smaller and may be easier to implant in some patients.
FDA says the approval was based on a company study of 137 advanced heart failure patients implanted with the device. Study results showed rates of adverse events, including infection and stroke, were similar to those seen with older devices.
Medical device maker HeartWare International Inc. is based in Framingham, Mass.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
A jury has convicted 16-year-old Dylan Schumaker of second degree murder in the death of his girlfriend's young son.
Police say a Mercedes Benz was making a left turn, when it failed to yield the right of way and struck the police car.
Deputies say they found 43 bags of crack cocaine when they executed a search warrant on a vehicle in Orleans County.
Lake Effect Snow Warning for S. Erie, Chautauqua, Cattaraugus, and Wyoming counties from Tues evening until Thurs morning
A Buffalo city jail cell block attendant was arrested early Saturday morning on multiple animal cruelty charges.
More than a dozen Buffalo teachers and a few parents picketed outside the home of NY State Regent Bob Bennett on Monday because he is a staunch supporter of Common Core standardized testing.